| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | Clinical implications of species identification in monomicrobial Aeromonas bacteremia | Wu C.-J.; Chen P.-L.; PO-REN HSUEH ; Chang M.-C.; Tsai P.-J.; Shih H.-I.; Wang H.-C.; Chou P.-H.; Ko W.-C. | PLoS ONE | 16 | ||
| 2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; YU-WEN TIEN ; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 45 | 42 | |
| 2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; CHING-YAO YANG ; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 45 | 41 | |
| 2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | Chang M.-C.; Chang Y.-T.; Chen J.-Y.; YUNG-MING JENG ; Yang C.-Y.; Tien Y.-W.; Yang S.-H.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 45 | 42 | |
| 2014 | Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan | Chang Y.-T.; Chang M.-C.; KAI-WEN HUANG ; Tung C.-C.; Hsu C.; Wong J.-M. | Journal of Gastroenterology and Hepatology (Australia) | 17 | 21 | |
| 2014 | Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan | Chang Y.-T.; Chang M.-C.; Huang K.-W.; Tung C.-C.; Chiun Hsu ; Wong J.-M. | Journal of Gastroenterology and Hepatology (Australia) | 17 | 21 | |
| 2014 | Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan | Chang Y.-T.; Chang M.-C.; Huang K.-W.; CHIEN-CHIH TUNG ; Hsu C.; Wong J.-M. | Journal of Gastroenterology and Hepatology (Australia) | 17 | 21 | |
| 2002 | Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma | Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; Yeh K.-H.; Wang C.-H.; CHIH-HUNG HSU ; Liu M.-Y.; Cheng A.-L. | Leukemia and Lymphoma | 9 | 5 | |
| 2002 | Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma | Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; HWEI-FANG TIEN ; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L. | Leukemia and Lymphoma | |||
| 2002 | Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma | Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG ; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L. | Leukemia and Lymphoma | 5 | ||
| 2014 | Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease | Tung C.-C.; Wong J.-M.; Lee W.-C.; Liu H.-H.; Chang C.-H.; Chang M.-C.; Chang Y.-T.; MING-JIUM SHIEH ; Wang C.-Y.; Wei S.-C. | Journal of Gastroenterology and Hepatology | 13 | 11 | |
| 2014 | Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease | CHIEN-CHIH TUNG ; Wong J.-M.; Lee W.-C.; Liu H.-H.; Chang C.-H.; Chang M.-C.; Chang Y.-T.; Shieh M.-J.; Wang C.-Y.; Wei S.-C. | Journal of Gastroenterology and Hepatology (Australia) | 13 | 11 | |
| 2014 | Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease | Tung C.-C.; Wong J.-M.; Lee W.-C.; Liu H.-H.; Chang C.-H.; Chang M.-C.; Chang Y.-T.; Shieh M.-J.; Wang C.-Y.; SHU-CHEN WEI | Journal of Gastroenterology and Hepatology (Australia) | 11 | ||
| 2006 | Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease | Liou J.-M.; Chen C.-Y.; MING-SHIANG WU ; Hsu M.-T.; Fang C.-C.; Lin Y.-G.; Chang M.-C.; Lin J.-T.; Wang H.-P. | Hepato-Gastroenterology | 2 | ||
| 2006 | Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease | Liou J.-M.; Chen C.-Y.; Wu M.-S.; Hsu M.-T.; Fang C.-C.; Lin Y.-G.; Chang M.-C.; Lin J.-T.; HSIU-PO WANG | Hepato-Gastroenterology | 2 | ||
| 2019 | Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer | Wu C.-H.; Chang M.-C.; Lyadov V.K.; Liang P.-C.; Chen C.-M.; TIFFANY TING-FANG SHIH ; Chang Y.-T. | Clinical Nutrition | 7 | 8 | |
| 2019 | Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer | CHIH-HORNG WU ; Chang M.-C.; Lyadov V.K.; Liang P.-C.; Chen C.-M.; Shih T.T.-F.; Chang Y.-T. | Clinical Nutrition | 7 | 6 | |
| 2019 | Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer | Wu C.-H.; Chang M.-C.; Lyadov V.K.; PO-CHIN LIANG ; Chen C.-M.; Shih T.T.-F.; Chang Y.-T. | Clinical Nutrition | 7 | 7 | |
| 2014 | Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort | Chang M.-C.; Liang P.-C.; Jan I.-S.; CHING-YAO YANG ; Tien Y.-W.; Wei S.-C.; Wong J.-M.; Chang Y.-T. | BMJ Open | 4 | 5 | |
| 2014 | Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort | Chang M.-C.; Liang P.-C.; Jan I.-S.; Yang C.-Y.; YU-WEN TIEN ; Wei S.-C.; Wong J.-M.; Chang Y.-T. | BMJ Open | 4 | 5 |
